| LIST.MY · Rpt Chemor | |||||
|---|---|---|---|---|---|
|
Road
|
Price
|
PSF
|
Size
|
Date
|
Type
|
| 2024 | |||||
|
Jalan Anggerik 18
|
RM250,000
|
RM62
|
4,050 sqft
|
|
Bungalow |
| 2023 | |||||
|
Jalan Anggerik 13
|
RM300,000
|
RM66
|
4,575 sqft
|
|
Bungalow |
| 2022 | |||||
|
Jalan Anggerik 11
|
RM200,000
|
RM49
|
4,051 sqft
|
|
Bungalow |
Posts about Rpt Chemor
No posts about Rpt Chemor yet. Be the first to share what’s happening here.
Nearby areas in Ulu Kinta
Bandar Baru Sri Klebang
Panorama Lapangan Perdana
Prima Meru
Taman Kinding Flora
Taman Cempaka
Bandar Baru Lapangan
Taman Klebang Putra
Bandar Seri Botani
Taman Polo Laguna @ Tambun
Taman Desa Lang Indah
Medan Klebang Restu
Taman Pertama (Silibin)
Rpt Chemor
PSF median price per sq ft · 12m its change over the past 12 months
Most-traded areas in this mukim, by number of recorded subsale transactions. See every area in Ulu Kinta
Rpt Chemor in Kinta, Perak recorded 3 subsale transactions between 2021 and 2026, sized between 2,000 and 5,000 sqft, with a median price of RM250K and a median price per square foot (PSF) of RM62.
This area consists exclusively of residential properties, with no commercial listings recorded.
Price remained flat, and PSF growth was PSF remained flat. The median price is RM250K, with most transactions falling within a stable range of RM209K to RM291K, and a typical market range of RM225K to RM275K.
Most transactions involved detached, with minimal variety in property types.
The median PSF stands at RM62, with core pricing between RM55 and RM69. Market pricing typically extends from RM57.48 to RM65.98, reflecting moderate variation in unit pricing. With an IQR of RM8.50 and MAD of RM7, the PSF demonstrates reasonable consistency across the market.
Overall, the market in this area appears stable with consistent appreciation, making it an attractive option for both investors and homebuyers. The consistent property type and stable pricing make it easier to assess value and compare trends. Limited transaction history suggests carefully evaluating comparable sales data.